In addition, a study focused on the chemoresistance triple-negative breast cancer (TNBC) revealed that down-regulating NEAT1 enhanced the sensitized cells to chemotherapy and reduced CD44+/CD24−, ALDH+, and SOX2+ cell populations, implicating that NEAT1 was closely related to cancer stemness and chemoresistance in TNBC [30]. The gene discussed is SOX2; the disease is triple-negative breast carcinoma.